3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Leukemia, Myeloid, Acute
197
Leukemia
110
Lymphoma
90
Precursor Cell Lymphoblastic Leukemia-Lymphoma
86
Burkitt Lymphoma
52
Myelodysplastic Syndromes
47
Lymphoma, Mantle-Cell
47
Lymphoma, Large B-Cell, Diffuse
47
Lymphoma, Non-Hodgkin
46
Leukemia, Myelomonocytic, Acute
30
Lymphoma, Follicular
29
Leukemia, Monocytic, Acute
29
Recurrence
25
Congenital Abnormalities
25
Leukemia, Erythroblastic, Acute
24
Lymphoma, Large-Cell, Immunoblastic
23
Leukemia, Megakaryoblastic, Acute
23
Blast Crisis
21
Hodgkin Disease
20
Leukemia, Lymphocytic, Chronic, B-Cell
18
Leukemia, Myelomonocytic, Chronic
17
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Lymphoma, B-Cell, Marginal Zone
15
Anemia, Refractory, with Excess of Blasts
15
Leukemia, Myeloid, Accelerated Phase
13
Leukemia, Biphenotypic, Acute
13
Leukemia, Myeloid, Chronic-Phase
12
Dendritic Cell Sarcoma, Interdigitating
12
Myeloproliferative Disorders
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Interventions
Docetaxel
137
Prednisone
120
Abiraterone Acetate
91
Leuprolide
86
enzalutamide
84
Radiotherapy
59
bicalutamide
56
Magnetic Resonance Spectroscopy
54
Goserelin
54
Androgen Antagonists
51
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
47
apalutamide
44
abiraterone
34
Radiosurgery
31
Specimen Handling
30
gallium 68 PSMA-11
29
Gonadotropin-Releasing Hormone
29
cabazitaxel
28
Carboplatin
27
darolutamide
26
Estramustine
24
luprolide acetate gel depot
23
relugolix
22
Metformin
22
Triptorelin Pamoate
20
sipuleucel-T
19
radium Ra 223 dichloride
19
Radiation
19
pembrolizumab
18
deltacortene
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Prostatic Neoplasms
×
Cytarabine
×
Clear all
NCT00480090
2019-02-15
SLAP
University Health Network, Toronto
Phase 2
Completed
10 enrolled